Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy

SIMPLE SUMMARY: Cancer immunotherapy is gaining attention as a potential fourth treatment following surgery, chemotherapy, and radiation therapy. Cancer stem cells have recently been recognized and validated as a key target for cancer treatment. Cripto-1, which is a GPI-anchored membrane-bound prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hiroko, Afify, Said M., Hassan, Ghmkin, Salomon, David S., Seno, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160785/
https://www.ncbi.nlm.nih.gov/pubmed/34065315
http://dx.doi.org/10.3390/cancers13102491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160785/
https://www.ncbi.nlm.nih.gov/pubmed/34065315
http://dx.doi.org/10.3390/cancers13102491

Ejemplares similares